OpenLegislation

Commission Regulation (EC) No 1490/2002 of 14 August 2002 laying down further detailed rules for the implementation of the third stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC and amending Regulation (EC) No 451/2000 (Text with EEA relevance) (revoked)

EU Regulation No 1490/2002 · Adopted 14 August 2002 · Extends to United Kingdom

Original text. legislation.gov.uk does not revise this item, so later amendments are not shown here. Changes made to it are listed under each provision when known.

Commission Regulation (EC) No 1490/2002

of 14 August 2002

laying down further detailed rules for the implementation of the third stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC and amending Regulation (EC) No 451/2000

(Text with EEA relevance) (revoked)

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annotations to the whole text

Textual amendments

F1

Regulation revoked (31.12.2020) by The Plant Protection Products (Miscellaneous Amendments) (EU Exit) Regulations 2019 (S.I. 2019/556), reg. 1(1), Sch. 2 Pt. 1 (with reg. 29(2)) (as amended by S.I. 2020/1376, regs. 1(4), 3(20)); 2020 c. 1, Sch. 5 para. 1(1)

Contents

  1. 1Subject matter and scope Repealed
  2. 2Definitions Repealed
  3. 3Member State authority Repealed
  4. 4Measures in case of imbalances Repealed
  5. 5Withdrawal or replacement of notifier Repealed
  6. 6Submission and checking of data lists Repealed
  7. 7Submission of dossiers Repealed
  8. 8Submission of information by third parties Repealed
  9. 9Completeness check of dossiers Repealed
  10. 10Evaluation by the rapporteur Member State Repealed
  11. 11Receipt of and access to the draft assessment report Repealed
  12. 11aExamination of the draft assessment report Repealed
  13. 11bActive substance with clear indications that they do not have any harmful effects Repealed
  14. 11cConsultation of the EFSA Repealed
  15. 11dSubmission of additional information after the draft assessment report has been submitted to the EFSA Repealed
  16. 11eWithdrawal by notifier Repealed
  17. 11fActive substance for which there are clear indications of harmful effects Repealed
  18. 12Presentation of a draft directive or draft decision Repealed
  19. 12aView by the EFSA Repealed
  20. 13Finalised review report Repealed
  21. 14Suspension of time limits Repealed
  22. 15Measures taken by Member States Repealed
  23. 16Interim progress report Repealed
  24. 17Fees Repealed
  25. 18Other charges, taxes, levies or fees Repealed
  26. 19Temporary measures Repealed
  27. 20Amendment to Regulation (EC) No 451/2000 Repealed
  28. 21Entry into force Repealed
  29. Signature
  30. Annex I: List of active substances (column A), rapporteur Member States (column B) and notifying producers (code identification) (column C) Repealed
  31. APart A Repealed
  32. BPart B Repealed
  33. Annex IIList of notifiers' code identification, names and addresses Repealed
  34. Annex III: Coordinating authority in the Member States (more details are available at the following website: http://www.europa.eu.int/comm/food/fs/ph_ps/pro/index_en.htm) Repealed
  35. AUSTRIA Repealed
  36. BELGIUM Repealed
  37. DENMARK Repealed
  38. GERMANY Repealed
  39. GREECE Repealed
  40. SPAIN Repealed
  41. FINLAND Repealed
  42. FRANCE Repealed
  43. IRELAND Repealed
  44. ITALY Repealed
  45. LUXEMBOURG Repealed
  46. NETHERLANDS Repealed
  47. PORTUGAL Repealed
  48. SWEDEN Repealed
  49. UNITED KINGDOM Repealed
  50. Annex IV: Organisations in the Member States to be contacted concerning further details on the payment of the fees referred to in Article 17 and to which such fees have to be paid Repealed
  51. AUSTRIA Repealed
  52. BELGIUM Repealed
  53. DENMARK Repealed
  54. GERMANY Repealed
  55. GREECE Repealed
  56. SPAIN Repealed
  57. FINLAND Repealed
  58. FRANCE Repealed
  59. IRELAND Repealed
  60. ITALY Repealed
  61. LUXEMBOURG Repealed
  62. THE NETHERLANDS Repealed
  63. PORTUGAL Repealed
  64. SWEDEN Repealed
  65. UNITED KINGDOM Repealed
  66. Annex VCriteria for clear indications of no harmful effects Repealed
  67. 1Division 1 Repealed
  68. 2Division 2 Repealed
  69. Annex VICriteria for clear indications of harmful effects Repealed
  70. 1Division 1 Repealed
  71. 2Division 2 Repealed

1Subject matter and scopeF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2DefinitionsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3Member State authorityF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4Measures in case of imbalancesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5Withdrawal or replacement of notifierF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

6Submission and checking of data listsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

7Submission of dossiersF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

8Submission of information by third partiesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

9Completeness check of dossiersF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

10Evaluation by the rapporteur Member StateF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11Receipt of and access to the draft assessment reportF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11aExamination of the draft assessment reportF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11bActive substance with clear indications that they do not have any harmful effectsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11cConsultation of the EFSAF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11dSubmission of additional information after the draft assessment report has been submitted to the EFSAF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11eWithdrawal by notifierF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

11fActive substance for which there are clear indications of harmful effectsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

12Presentation of a draft directive or draft decisionF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

12aView by the EFSAF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

13Finalised review reportF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

14Suspension of time limitsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

15Measures taken by Member StatesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

16Interim progress reportF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

17FeesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

18Other charges, taxes, levies or feesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

19Temporary measuresF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

20Amendment to Regulation (EC) No 451/2000F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

21Entry into forceF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Signature

F1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annex IIList of notifiers' code identification, names and addressesF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AUSTRIAF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BELGIUMF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DENMARKF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GERMANYF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GREECEF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SPAINF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FINLANDF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FRANCEF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

IRELANDF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ITALYF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LUXEMBOURGF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

NETHERLANDSF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PORTUGALF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SWEDENF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

UNITED KINGDOMF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

AUSTRIAF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

BELGIUMF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

DENMARKF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GERMANYF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

GREECEF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SPAINF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FINLANDF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

FRANCEF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

IRELANDF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ITALYF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LUXEMBOURGF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

THE NETHERLANDSF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PORTUGALF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

SWEDENF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

UNITED KINGDOMF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annex VCriteria for clear indications of no harmful effectsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annex VICriteria for clear indications of harmful effectsF1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2F1

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .